AbCellera Biologics Ownership | Who Owns AbCellera Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

AbCellera Biologics Ownership Summary


AbCellera Biologics is owned by 36.08% institutional investors, 22.94% insiders, and 40.98% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 9.25% of ABCL shares. American Funds SMALLCAP World A is the top mutual fund, with 4.48% of its assets in AbCellera Biologics shares.

ABCL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAbCellera Biologics36.08%22.94%40.98%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp27.53M9.25%$94.41M
Capital world investors13.36M4.49%$45.83M
Baillie gifford12.24M4.15%$35.85M
Ubs asset management americas4.50M1.53%$13.19M
Arrowmark colorado4.11M1.38%$14.08M
Blackrock3.80M1.30%$11.26M
Blackrock funding, inc. /de3.68M1.24%$12.63M
Orbimed advisors3.34M1.12%$11.47M
Two sigma investments, lp3.26M1.10%$9.54M
Two sigma advisers, lp2.61M0.88%$7.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baker bros. advisors lp27.53M0.92%$94.41M
Guardian partners1.79M0.68%$7.54M
Guardian capital advisors lp1.79M0.53%$5.00M
Tang capital management2.60M0.45%$8.92M
Intellectus partners548.13K0.41%$1.88M
Orbimed advisors3.34M0.29%$11.47M
Arrowmark colorado4.11M0.25%$14.08M
Novo652.53K0.16%$2.24M
Pier 88 investment partners244.18K0.16%$837.54K
Entrypoint capital89.57K0.15%$307.23K

Top Buyers

HolderShares% AssetsChange
Ubs group1.98M0.00%1.95M
Norges bank1.28M0.00%1.28M
Millennium management1.48M0.00%728.83K
Two sigma investments, lp3.26M0.02%723.68K
Driehaus capital management499.92K0.01%499.92K

Top Sellers

HolderShares% AssetsChange
Voya investment management---10.62M
Founders fund vii management---3.77M
Prosight management, lp---2.82M
Casdin capital---2.36M
Federated hermes916.24K0.01%-1.37M

New Positions

HolderShares% AssetsChangeValue
Norges bank1.28M0.00%1.28M$3.76M
Driehaus capital management499.92K0.01%499.92K$1.71M
Moloney securities asset management90.40K0.04%90.40K$264.87K
Prelude capital management64.81K0.02%64.81K$222.31K
Headlands37.80K0.02%37.80K$129.64K

Sold Out

HolderChange
Gamma investing-46.00
Morton brown family wealth-75.00
Continuum advisory-93.00
Atticus wealth management-100.00
Rhumbline advisers-135.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025131-2.24%107,406,760-13.88%362.06%5420.00%45-10.00%
Mar 31, 2025134-10.67%124,719,7849.52%412.81%46-34.29%4922.50%
Dec 31, 20241472.80%113,857,4378.74%383.06%69-4.17%3918.18%
Sep 30, 2024140-8.50%104,569,721-8.52%352.33%7020.69%34-29.17%
Jun 30, 2024153-4.38%114,320,602-4.79%392.28%59-21.33%479.30%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A13.36M4.48%-
Allianz Global Artfcl Intlgc W EUR6.17M2.07%-7.81K
UBS (Lux) Digital Health Equity SB USD4.50M1.51%-
SMDS Global AI Equity Mother4.49M1.50%-
Baillie Gifford Positive Change B Acc4.02M1.35%-284.71K
Baillie Gifford Positive Change3.89M1.30%-143.60K
UBS Lux Dgtl Hlth Eq Fd seeding P acc3.40M1.14%-72.96K
American Funds IS® Asset Allocation 12.87M0.97%-
Baillie Gifford WW Pstv Chg B USD Acc2.33M0.78%-107.66K
ACATIS Datini Valueflex Fonds A1.86M0.62%860.00K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 11, 2025Thermopylae Holdings Ltd.-Buy$742.24K
Mar 10, 2025Montalbano John S.-Buy$57.50K
Mar 06, 2025Montalbano John S.-Buy$140.57K
Aug 29, 2024Thermopylae Holdings Ltd.-Buy$739.98K
Nov 06, 2023Montalbano John S.-Buy$92.80K

Insider Transactions Trends


DateBuySell
2025 Q13-
2024 Q4--
2024 Q31-
2024 Q2--
2024 Q1--

ABCL Ownership FAQ


Who Owns AbCellera Biologics?

AbCellera Biologics shareholders are primarily institutional investors at 36.08%, followed by 22.94% insiders and 40.98% retail investors. The average institutional ownership in AbCellera Biologics's industry, Biotech Stocks , is 306.59%, which AbCellera Biologics falls below.

Who owns the most shares of AbCellera Biologics?

AbCellera Biologics’s largest shareholders are Baker bros. advisors lp (27.53M shares, 9.25%), Capital world investors (13.36M shares, 4.49%), and Baillie gifford (12.24M shares, 4.15%). Together, they hold 17.88% of AbCellera Biologics’s total shares outstanding.

Does Blackrock own AbCellera Biologics?

Yes, BlackRock owns 1.30% of AbCellera Biologics, totaling 3.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.26M$. In the last quarter, BlackRock decreased its holdings by -97.087K shares, a -2.49% change.

Who is AbCellera Biologics’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is AbCellera Biologics’s biggest shareholder by percentage of total assets invested, with 0.92% of its assets in 27.53M AbCellera Biologics shares, valued at 94.41M$.

Who is the top mutual fund holder of AbCellera Biologics shares?

American Funds SMALLCAP World A is the top mutual fund holder of AbCellera Biologics shares, with 4.48% of its total shares outstanding invested in 13.36M AbCellera Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools